Evaluation of a solubilized benzoyl peroxide gel: A pooled analysis from 3 randomized investigator-blinded clinical trials

Cosmetic Dermatology

Volumn 21, Issue 4, 2008, Pages 201-206

  Del Rosso, James Q ^a,b,c  

^a UNIVERSITY OF NEVADA   (United States)

^b TOURO UNIVERSITY NEVADA   (United States)

^c The Valley Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953956658     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Tanghetti E, Kircik L, Dhawan S, et al. A multi-center, investigatorblinded, randomized study to evaluate the efficacy and tolerability of a solubilized 5% benzoyl peroxide compated to a 5% benzoyl peroxide/clindamycin gel in the treatment of moderate facial acne vulgaris (Protocol 010a). Poster presented at: Winter Clinical Dermatology Conference; March 14-18, 2008; Maui, Hawaii.
2. Wilson DC, Meadows K P, Ramirez J. A comparison of a novel benzoyl peroxide system with a combination benzoyl peroxide and clindamycin product: a 2-week split-face study of effectiveness and tolerability. Poster presented at: 65th Annual Meeting of the American Academy of Dermatology; February 2-6, 2007; Washington, DC.
3. Wilson DC. Evaluation of a novel acne treatment system designed to enhance the efficacy of benzoyl peroxide treatment: an investigator-blind, randomized study. Poster presented at: Summer Meeting of the American Academy of Dermatology; August 1-5, 2007; New York, NY.
4. ™: introducing a breakthrough acne solution from Obagi. http://www.obagi.com/article/forpatients/ obagiclenzidermmd/clenziderm.html. Accessed February 12, 2008.